Trial Profile
Detection of Plaque Inflammation and Visualization of Anti-Inflammatory Effects of Pioglitazone on Plaque Inflammation in Subjects With Impaired Glucose Tolerance and Type 2 Diabetes Mellitus by FDG-PET/CT
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary) ; Glimepiride
- Indications Atherosclerosis; Glucose intolerance; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 07 Aug 2008 New trial record.